Dental implications of osteogenesis imperfecta: Treatment with IV bisphosphonate: Report of a case

Pediatric Dentistry

Volumn 33, Issue 4, 2011, Pages 349-352

  Milano, Michael ^a   Wright, Timothy ^a   Loechner, Karen J ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

B isphosphonate; Dental extractions; Detinogenesis imperfecta; Osteogenesis imperfecta; Osteonecrosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; PAMIDRONIC ACID;

ARTICLE; BONE NECROSIS; CASE REPORT; CHEMICALLY INDUCED DISORDER; DENTAL SURGERY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; JAW DISEASE; MALE; OSTEOGENESIS IMPERFECTA; PRESCHOOL CHILD; RISK FACTOR; TOOTH EXTRACTION;

BONE DENSITY CONSERVATION AGENTS; CHILD, PRESCHOOL; DENTAL RESTORATION, PERMANENT; DIPHOSPHONATES; HUMANS; INJECTIONS, INTRAVENOUS; JAW DISEASES; MALE; OSTEOGENESIS IMPERFECTA; OSTEONECROSIS; RISK FACTORS; TOOTH EXTRACTION;

EID: 80051941223     PISSN: 01641263     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Huth KCH, Paschos E, Sagner T, Hickel R. Diagnostic features and pedodontic-orthodontic management in dentinogenesis imperfecta type III: A case report. Int J Paediatr Dent 2002;12:316-21.
2. Rauch F, Glorieux FH. Osteogenesis imperfecta: Current and future medical treatment. Am J Med Gen 2005;139:31-7. (Pubitemid 41739245)
3. Hubner MA. Osteogenesis imperfecta. Oral Surg Oral Med Oral Path Oral Rad Endo 2007;103:314-20.
4. Chevrel G, Cimaz R. Osteogenesis imperfecta: New treatment options. Curr Rheumatol Rep 2006;8: 474-9. (Pubitemid 46112741)
5. Ormiston IW, Tideman H. Orthognathic surgery in osteogenesis imperfecta: A case report with management considerations. J Craniomaxillofac Surg 1995;23:261-5.
6. Graham R, Russell G. Bisphosphonates: Mode of action and pharmacology. Pediatrics 2007;119:150-62.
7. Reid IR. Bisphosphonates: New indications and methods of administration. Curr Op Rheumatol 2003; 15:458-63. (Pubitemid 36774259)
8. O'Connell AC, Marini JC. Evaluation of oral problems in an osteogenesis imperfecta population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87: 189-96.
9. Kindelan J, Tobin M, Roberts-Harry D, Loukota RA. Orthodontic and orthognathic management of a patient with osteogenesis imperfecta: A case report. J Orthod 2003;30:291-6.
10. Pizones J, Plotkin H, Parra-Garcia JI, et al. Bone healing in children with osteogenesis imperfecta treated with bisphosphonates. J Pediatr Orthop 2005;25:332-5. (Pubitemid 40594071)
11. Thornton J, Ashcroft DM, Mughal MZ, Elliott RA, O'Neill TW, Symmons D. Systematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritis. Arch Dis Child 2006;91:753-61. (Pubitemid 44351176)
12. Shaw NJ, Bishop NJ. Bisphosphonate treatment of bone disease. Arch Dis Child 2005;90:494-9. (Pubitemid 40627446)
13. Glorieux FH. Experience with bisphosphonates in osteogenesis imperfecta. Pediatrics 2007;119:163-5.
14. Antoniazzi F, Zamboni G, Lauriola S, Donadi L, Adami S, Tato L. Early bisphosphonate treatment in infants with severe osteogenesis imperfecta. J Pediatr 2006;149:174-9. (Pubitemid 44128547)
15. Grissom LE, Harcke HT. Radiographic features of bisphosphonates therapy in pediatric patients. Pediatr Radiol 2003;33:226-9. (Pubitemid 36700932)
16. Papapoulos SE, Cremers S. Prolonged bisphosphonate release after treatment in children. New Engl J Med 2007;356:1075-6. (Pubitemid 46376827)
17. Grbic JT, Landesberg R, Lin SQ, et al. Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly in pivotal fracture trial. J Am Dent Assoc 2008;139:32-40.
18. Malmgren B, Astrom E, Soderhall S. No osteonecrosis in the jaws of young patients with osteogenesis imperfecta treated with bisphosphonates. J Oral Pathol Med 2008;37:196-200. (Pubitemid 351347604)
19. Schwartz S, Joseph C, Iera D, et al. Bisphosphonates, osteonecrosis, osteogenesis imperfecta, and dental extractions: A case series. J Can Dent Assoc; 74:537-42.
20. Cartsos VM, Zhu S, Zavras AI. Bisphosphonate use and the risk of adverse jaw outcomes: A medical claims study of 714,217 people. J Am Dent Assoc 2008;139:23-30.
21. Kamoun-Goldrat A, Ginisty D, Le Merrer M. Effects of bisphosphonates on tooth eruption in children with osteogenesis imperfect. Eur J Oral Sci 2008;116: 195-8.